MYCF yields 4.46% · JNJ yields 3.36%● Live data
📍 MYCF pulled ahead of the other in Year 1
Combined, MYCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MYCF + JNJ for your $10,000?
The State Street My2026 Corporate Bond ETF employs an actively managed target maturity strategy that provides exposure primarily to corporate bonds maturing in 2026 and is designed to distribute any remaining principal and liquidate on or about December 15, 2026.The fund seeks to maximize current income while seeking preservation of capital using a risk-aware, top-down approach combined with bottom-up security selection through rigorous fundamental research to construct a portfolio that seeks to overweight the most attractive sectors and issuers.The fund is one of the State Street MyIncome ETFs, a suite of target maturity funds allowing investors to efficiently build custom bond ladder portfolios to manage interest rate risks, cash flows, and liquidity needs.
Full MYCF Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.